» Articles » PMID: 857581

Neuraxonal Dystrophy of the Brain in Patients Receiving Antineoplastic Chemotherapy

Overview
Specialty Neurology
Date 1977 Mar 31
PMID 857581
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

The present report describes the neuropathological change found in the brainstem of four patients who were treated with combined chemotherapy for various types of malignant disease. The change consists of localized axonal swellings, the so-called "axonal spheroids" located predominantly in the medial lemniscus, the fibers from the olivary nuclei and around some of the cranial nerve nuclei. In addition to the brain change, all four patients had shown histological evidence of hepatic injury, although none of the patients exhibited overt clinical or chemical evidence of hepatic insufficiency. Neither did these patients show any clinical neurological deficit that could be related to the pathological findings. The neuroaxonal changes are most likely the result of altered metabolism as a consequence of the chemotherapy.

Citing Articles

Diagnosis of juvenile-adult form of neuroaxonal dystrophy by electron microscopy of rectum and skin biopsy.

Schwendemann G, Arendt G, Noth J, Lange H, Strauss W J Neurol Neurosurg Psychiatry. 1987; 50(6):818-21.

PMID: 3612164 PMC: 1032100. DOI: 10.1136/jnnp.50.6.818.


Reactive neuroaxonal dystrophy in children. Clinical pathological correlation.

Mei Liu H Acta Neuropathol. 1978; 42(3):237-41.

PMID: 676673 DOI: 10.1007/BF00690363.

References
1.
Wisniewski H, KARCZEWSKI W, Wisniewska K . Neurofibrillary degeneration of nerve cells after intracerebral injection of aluminium cream. Acta Neuropathol. 1966; 6(3):211-9. DOI: 10.1007/BF00687851. View

2.
Weiss H, Walker M, Wiernik P . Neurotoxicity of commonly used antineoplastic agents (first of two parts). N Engl J Med. 1974; 291(2):75-81. DOI: 10.1056/NEJM197407112910205. View

3.
Wang J, Cortes E, Sinks L, HOLLAND J . Therapeutic effect and toxicity of adriamycin in patients with neoplastic disease. Cancer. 1971; 28(4):837-43. DOI: 10.1002/1097-0142(1971)28:4<837::aid-cncr2820280406>3.0.co;2-4. View

4.
Wisniewski H, Terry R, Hirano A . Neurofibrillary pathology. J Neuropathol Exp Neurol. 1970; 29(2):163-76. View

5.
Bleyer W, Drake J, Chabner B . Neurotoxicity and elevated cerebrospinal-fluid methotrexate concentration in meningeal leukemia. N Engl J Med. 1973; 289(15):770-3. DOI: 10.1056/NEJM197310112891503. View